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Background: Little is known about the criteria nephrologists use in the decision of when to start renal
replacement therapy (RRT) in early referred adult patients. We evaluated opinions of European nephrologists
on the decision for when to start RRT.
Study Design: European web-based survey.
Predictors: Patient presentations described as uncomplicated patients, patients with unfavorable clinical
and unfavorable social conditions, or patients with specific clinical, social, and logistical factors.
Setting & Participants: Nephrologists from 11 European countries.
Outcomes & Measurements: We studied opinions of European nephrologists about the influence of
clinical, social, and logistical factors on decision making regarding when to start RRT, reflecting practices in
place in 2009. Questions included target levels of kidney function at the start of RRT and factors accelerating or
postponing RRT initiation. Using linear regression, we studied determinants of target estimated glomerular
filtration rate (eGFR) at the start of RRT.
Results: We received 433 completed surveys. The median target eGFR selected to start RRT in uncomplicated
patients was 10.0 (25th-75th percentile, 8.0-10.0) mL/min/1.73 m2. Level of excretory kidney function was
considered the most important factor in decision making regarding uncomplicated patients (selected by 54% of
respondents); in patients with unfavorable clinical versus social conditions, this factor was selected by 24% versus
32%, respectively. Acute clinical factors such as life-threatening hyperkalemia refractory to medical therapy (100%)
and uremic pericarditis (98%) elicited a preference for an immediate start, whereas patient preference (69%) and
vascular dementia (66%) postponed the start. Higher target eGFRs were reported by respondents from high-
versus low-RRT-incidence countries (10.4 [95% CI, 9.9-10.9] vs 9.1 mL/min/1.73 m2) and from for-profit versus
not-for-profit centers (10.1 [95% CI, 9.5-10.7] vs 9.5 mL/min/1.73 m2).
Limitations: We were unable to calculate the exact response rate and examined opinions rather than
practice for 433 nephrologists.
Conclusions: Only for uncomplicated patients did half the nephrologists consider excretory kidney function
as the most important factor. Future studies should assess the weight of each factor affecting decision making.
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Survey on When to Start Renal Replacement TherapyPatients with end-stage renal disease (ESRD) re-ceive renal replacement therapy (RRT) to im-
prove their survival and quality of life. The decision
of when to start RRT is likely to be guided by the level
and rate of decrease in residual kidney function and
the clinical condition of the patient. Whereas RRT
might be life-saving in certain conditions, dialysis
also is unphysiologic and may have life-threatening
complications. It carries a significant burden for pa-
tients and consumes substantial health care re-
sources.1 Many studies evaluating associations be-
tween the timing of the start of RRT and survival were
limited in that they considered only serum creatinine
level, which is decreased in patients with deteriorating
nutritional status, as a surrogate marker of residual
kidney function and an index to define “early” versus
“late” starters. In addition, they were unable to assess
clinical status or specific reasons to start RRT at a
particular moment in time.2-5
The IDEAL (Initiating Dialysis Early and Late)
trial was the first randomized controlled trial attempt-
ing to assess whether starting dialysis therapy at high
(10-14 mL/min/1.73 m2) or low (5-7 mL/min/1.73
m2) estimated glomerular filtration rates (eGFRs) is
more beneficial with respect to patient survival. How-
ever, 76% of patients randomly assigned to start at
low eGFRs actually started at higher levels because of
uremic signs and symptoms, resulting in a relatively
small difference in eGFRs between the groups.6 The
study failed to show a survival difference between
those randomly assigned to start dialysis therapy with
higher and lower eGFRs, possibly because of this
relatively small difference, but suggested that clinical
status is important in the decision making of nephrolo-
gists.6-8 Nevertheless, little is known about exactly
which criteria nephrologists use in their decision for
when to start dialysis therapy.
Better understanding of nephrologists’ decision
making regarding the start of RRT would assist
further studies relating residual kidney function and
signs and symptoms at the start of dialysis therapy
to prognosis. This ultimately would guide us to
define better care for patients with ESRD. We
aimed to evaluate current opinions on how clinical,
social, and logistical factors influence the decision
of when to start RRT in early referred adult patients
by performing a survey of European nephrologists.
Furthermore, we assessed whether opinions dif-
fered by nephrologists’ or facilities’ characteristics.
METHODS
Contents of the Survey
We developed a 26-item web-based survey using the online
tool SurveyMonkey (SurveyMonkey.com). The survey was in
English and contained multiple-choice and open-ended ques-
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function in relation to the start of RRT, factors bringing forward
or postponing the start of RRT, factors causing a delay in the
planned start, and nephrologists’ and facilities’ characteristics.
The survey was administered in autumn 2010, but all respon-
dents were asked to provide their opinions and clinical practice
in place in 2009, before publication of the IDEAL trial.6 In
addition, we asked whether opinions had changed between 2009
and the moment of survey completion.
Clarity and face validity of the survey content were tested
during a pilot study of 20 nephrologists from France, Italy, the
Netherlands, and the United Kingdom. Based on the feedback
obtained, we added questions about reasons for delay of the
planned start and whether opinions changed in the recent past. A
copy of the survey is provided as Item S1 (available as online
supplementary material).
Design
Through national representatives and national societies of ne-
phrology of 11 European countries, we distributed the survey
along with a cover letter by e-mail to all nephrologists in the
country for whom an e-mail address was available. Four weeks
later, we sent a reminder to nonresponders and those who partially
completed the survey. Two weeks thereafter, another reminder was
sent, together with an e-mail from the national representative
stressing the importance of this survey. Survey completion was
voluntary and invitations included the option to decline: those
opting out were not contacted further. Responses were collected
and analyzed anonymously.
Deﬁnitions
In scenarios presented to nephrologists we used the following
definitions. Uncomplicated patients were defined as those without
malnutrition/inflammation (wasting), fluid overload, hyperkale-
mia, or major comorbid conditions. Examples of unfavorable
clinical conditions were defined as including malnutrition/
inflammation (wasting), fluid overload, hyperkalemia, mental dis-
orders, or major comorbid conditions. Examples of unfavorable
social conditions were defined as including a lack of social
support, living alone or incapable to perform exchanges them-
selves (peritoneal dialysis), treatment nonadherence, or language
barriers.
DataProcessing andAnalysis
The completed surveys were downloaded and stored and subse-
quently analyzed using SPSS version 16.0 (SPSS Inc, www.spss.
com). We applied descriptive statistics and calculated median
(25th-75th percentile) values and minimum-maximum ranges for
skewed data. Associations were tested using 2 tests, t tests, and
Mann-Whitney U tests. With univariable and multivariable linear
regression, we studied associations between nephrologists’ (age,
sex, and residency in a low- or high-RRT-incidence country) and
facility characteristics (academic vs nonacademic, private vs pub-
lic, and for-profit vs not-for-profit centers) and eGFR at the start of
dialysis therapy. Countries were classified as low or high incidence
when the age- and sex-adjusted RRT incidence per million popula-
tion (at day 91 after starting RRT) was lower or higher than the
median of participating countries as extracted from the 2008
Annual Report of the ERA-EDTA (European Renal Association-
European Dialysis and Transplant Association) Registry.9 To fulfil
criteria for linear regression analysis, we log-transformed eGFR
values. For easier interpretation, we added the intercept to the
estimated  coefficient and consequently transformed this back to
obtain median eGFRs. We adjusted the models for factors fulfilling
criteria for confounding, obtaining adjusted eGFRs.10 Potential
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van de Luijtgaarden et alconfounders were sex, age, country, and working in a for-profit
center. A 2-sided P 0.05 was considered statistically significant.
RESULTS
SurveyRespondents
We obtained 433 completed surveys from nephrolo-
gists in Belgium, Croatia, Germany, Finland, Greece,
Italy, FYR of Macedonia, the Netherlands, Roma-
nia, Spain, and the United Kingdom. Because we
did not know how many of those receiving the
survey were nephrologists and not all nephrologists
are involved in decision making on when to start
RRT, we were unable to determine the number of
recipients eligible for participation in the survey.
For reasons of data protection, it was not possible to
distribute the survey in all countries ourselves.
Therefore, the national societies of nephrology cir-
Table 1. Characteristics of Ne
Total (N 433)
Country of residence
Finland —
Italy —
Romania —
Spain —
The Netherlands —
United Kingdom —
Belgiuma —
Croatia —
FYR of Macedonia
Germany —
Greece —
Male sex 280 (65)
Age
44 y 178 (41)
45-64 y 247 (57)
65 y 8 (2)
Years of experience
14 y 246 (57)
15-34 y 171 (39)
35 y 16 (4)
Facility type
Public vs private
Public 350 (81)
Private 83 (19)
Setting
Academic 199 (46)
Nonacademic 234 (54)
Profit status
For profit 100 (23)
Not for profit 333 (77)
Note: Percentages are column percentages. Data are presente
Abbreviations: FYR, former Yugoslav Republic; RRT, renal rep
aDutch-speaking part (Flanders).culated a link to the survey. As a result, our soft-
942ware could not trace how many nephrologists re-
ceived or opened the survey and we were unable to
assess the exact response rate. If we would assume
that all recipients (excluding bounced e-mails) re-
ceived the survey and were eligible respondents,
response rates would range from 1% (n  6 in
Italy) to 44% (n  15 in FYR of Macedonia). Table
1 lists characteristics of responding nephrologists.
Sixty-five percent were men, and most nephrolo-
gists worked in public not-for-profit centers (71%);
13%, in private for-profit centers; 10%, in public
for-profit centers; and 6%, in private not-for-profit
centers. The survey reflected opinions in 2009, thus
before publication of results from the IDEAL trial.
Only 8% indicated that their opinions had changed
at the time of the survey (autumn 2010); they
reported that these changes were based on literature
logists and Treatment Centers
Incidence Level of RRT in Country
Pw (n 251) High (n 182)
35 (8) —
6 (1) —
18 (4) —
53 (12) —
51 (12) —
88 (20) —
— 37 (9)
— 17 (4)
15 (3)
— 69 (16)
— 44 (10)
159 (63) 121 (67) 0.5
0.4
107 (43) 71 (39)
141 (56) 106 (58)
3 (1) 5 (3)
0.7
147 (59) 99 (54)
95 (38) 76 (42)
9 (4) 7 (4)
0.001
240 (96) 110 (60)
11 (4) 72 (40)
0.04
126 (50) 73 (40)
125 (50) 109 (60)
0.001
31 (12) 69 (38)
220 (88) 113 (62)
number (percentage).
ent therapy.phro
Lo
d as
lacem(46%) and their own clinical experience (14%).
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Survey on When to Start Renal Replacement TherapyResidual Kidney Function
Level of residual kidney function may be assessed
using various methods. Of 433 (100%) respondents,
220 (51%) used one method: 179 respondents (41%)
used a formula exclusively (eg, MDRD [Modification
of Diet in Renal Disease] Study equation or Cockroft-
Gault formula), whereas 41 (9%) reported sole use of
another method, such as measured 24-hour creatinine
clearance (n  22) or the mean of measured 24-hour
creatinine and urea clearance (n 13). The other 213
respondents used multiple methods. Of these, 198
(46%) used a formula plus another method, such as
measured 24-hour creatinine clearance (n  78), the
mean of measured 24-hour creatinine and urea clear-
ance (n 34), or a combination of these 2 (n 23).
Table 2 lists median values for residual kidney
function at which nephrologists aimed to start RRT in
uncomplicated patients; for eGFR, the median target
level was 10 (25th-75th percentile, 8-10) mL/min/
1.73 m2, although this varied widely (Fig 1). The
importance of level of excretory kidney function in
the decision for when to start RRT was evaluated for:
(1) uncomplicated patients, (2) patients with unfavor-
able clinical conditions, and (3) patients with unfavor-
able social conditions. For uncomplicated patients,
54% of respondents considered excretory kidney func-
tion as the most important factor in their decision to
start RRT, whereas percentages were lower for pa-
tients with unfavorable clinical (24%) and social
conditions (32%).
Figure 2 summarizes results regarding the per-
ceived clinical benefit of starting RRT at GFR 10.5
mL/min/1.73 m2. Most (86%) believed that starting at
higher GFRs is beneficial only in the presence of
symptoms, with “reduction of emergency-start dialy-
sis” as the main reason. Some respondents stressed
Table 2. Stated Target Kidney Function as Start Time for RRT
Measure of Residual
Kidney Function No. Mediana
Range
(min-max)
eGFR (mL/min/1.73 m2) 382 10 [8-10] 5-20
Calculated residual GFR
(mL/min)
130 10 [8-12] 5-20
Plasma urea (mmol/L) 117 33 [31-40] 11-50
Serum creatinine (mol/L) 127 650 [530-780] 353-1,501
Note: Respondents were asked the following question: “Con-
sider a nondiabetic, uncomplicated 60-years old male patient
(weight 80 kg, height 1.80 m) in whom you confidently anticipate
a further decline of renal function. On average, at what level of
residual renal function do you aim to start RRT?” Conversion
factor for serum creatinine in mol/L to mg/dL,0.0113.
Abbreviations: eGFR, estimated glomerular filtration rate; min,
minimum; max, maximum; RRT, renal replacement therapy.
aThe 25th-75th percentile is given in brackets.that patients are receiving frequent medical supervi-
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and those eligible for transplant are placed on the
waiting list earlier. Reduction of emergency-start of
dialysis was also the most important motive for respon-
dents (11%) believing that starting at GFR 10.5
mL/min/1.73 m2 was always beneficial.
Comparing countries with a low versus high RRT
incidence, we found that respondents from high-
incidence countries (18%) more often believed that
starting at GFR 10.5 mL/min/1.73 m2 is always
beneficial compared with respondents from low-
incidence countries (6%). None of the respondents
from for-profit centers believed that starting at GFR
10.5 mL/min/1.73 m2 was never beneficial.
Determinants of Level of eGFRat the Start of RRT
We assessed associations between nephrologists’
and facilities’ characteristics and the target eGFR at
the start of RRT (Table 3). Adjusted target eGFRs
were significantly higher for respondents from high-
incidence countries than from low-incidence coun-
tries: 10.4 mL/min/1.73 m2 (95% confidence interval
[CI], 9.9-10.9) versus 9.1 mL/min/1.73 m2. Also,
female nephrologists aimed to start at higher levels
(adjusted eGFR, 10.2 mL/min/1.73 m2) compared
with males (adjusted eGFR, 9.4; 95% CI, 8.9-10.0
mL/min/1.73 m2), as well as nephrologists from for-
profit versus not-for-profit facilities (adjusted eGFRs
of 10.1 [95% CI, 9.5-10.7] vs 9.5 mL/min/1.73 m2).
FactorsAccelerating the Initiationof RRT
Respondents were asked to consider a hypothetical
patient with a residual kidney function at which they
usually would decide to postpone treatment and to
indicate how the presence of specific conditions would
affect their decision. When respondents opted for
either “immediate start of dialysis (with an acute
access)” or “start of dialysis when a permanent access
0
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Figure 1. Level of estimated glomerular filtration rate (eGFR)
at which nephrologists aimed to start renal replacement therapy
in uncomplicated patients.
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van de Luijtgaarden et alis ready,” this indicated they were inclined to acceler-
ate the initiation of dialysis therapy. All factors pre-
sented in the survey (Table 4) accelerated RRT initia-
tion to some extent. In the presence of chronic
conditions such as diabetes mellitus and chronic heart
disease, 60% and 65% of nephrologists would start
dialysis sooner. A majority considered an immediate
start of dialysis therapy in the presence of more acute
clinical phenomena, such as uremic symptoms (86%)
and fluid overload refractory to diuretic therapy (97%).
Another common reason for an earlier start of RRT
(including transplant) was the availability of a match-
ing pre-emptive transplant (kidney or kidney-pan-
creas) from a living donor (70%).
Compared with respondents from high-incidence
countries, those from low-incidence countries less
commonly indicated that they would start dialysis
therapy sooner in the presence of several chronic
conditions, for example, at older than 75 years (36%
vs 45%; P  0.01), the presence of chronic heart
disease (59% vs 73%; P  0.001), vascular dementia
(17% vs 43%; P 0.001), and cirrhosis/chronic liver
disease (42% vs 60%; P  0.001). There were no
differences between nephrologists working in for-
profit and not-for-profit centers.
Factors Postponing the Start of RRT
To evaluate the extent to which some conditions
prompted nephrologists to postpone the start of RRT,
respondents considered a hypothetical uncomplicated
patient with a level of kidney function at which they
usually would start dialysis therapy. Patient prefer-
ence (69%) and vascular dementia (66%) were the
most important factors in postponing the start of
dialysis therapy (Table 5). Compared with respon-
dents from high-incidence countries, those from low-
incidence countries were more likely to postpone
dialysis therapy in the presence of a (relative) lack of
capacity in the dialysis facility (33% vs 20%; P 
0.04) and vascular dementia (73% vs 58%; P 
Most frequently m
     Yes, starting a
  - Reduction of em
  - Improved quality
  - Improved patien
     Yes, but only i
  - Reduction of em
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  - Improved patien
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3%
Figure 2. Attitudes toward early initiation of dialysis. Respond
GFR10.5 mL/min/1.73 m2) is beneficial?” Abbreviations: GFR,0.001).
944FactorsDelaying thePlannedStart of RRT
Notwithstanding a nephrologist’s preference to start
RRT at a particular moment in time, initiation may be
delayed. According to 7%, RRT initiation was never
delayed; 79% answered that fewer than half their
patients started later than considered ideal; and for
14%, RRT initiation was delayed in at least half their
patients. Common reasons for delay were patient
preference (65%), lack of adequate preparation for
dialysis treatment (32%), or lack of dialysis facilities
(8%). Further reasons included good clinical condi-
tion (8%) and unexpected deterioration in kidney
function or late referral (5%). Most (77%) reported
never having a waiting list for long-term dialysis
treatment at their unit, and others indicated that they
often (4%) or always (3%) had a waiting list. A
waiting list was present more often in not-for-profit
compared with for-profit centers (26% vs 10%; P 
0.01), in public than in private centers (26% vs 7%;
P  0.02), and in low- versus high-incidence coun-
tries (30% vs 12%; P  0.001).
DISCUSSION
This international survey evaluated current opin-
ions of European nephrologists on how clinical, so-
cial, and logistical factors influence their decision to
start RRT in early referred adult patients with ESRD.
Only a third of all nephrologists considered level of
excretory kidney function as the most important fac-
tor in their decision making; for uncomplicated pa-
tients, about half of all nephrologists selected this as
the most important factor. Factors eliciting an immedi-
ate start were life-threatening hyperkalemia refractory
to other therapy, uremic pericarditis, and fluid over-
load refractory to diuretic therapy. Patient preference
and vascular dementia were reasons to postpone the
start.
The most recent European guideline at the time of
the survey, the European Renal Best Practice Guide-
ned reasons as basis for opinion  (% of n=433) 
R>10.5 ml/min/1.73m2 is always beneficial (n=48) 
cy start of dialysis (9%) 
 (7%) 
val (8%) 
associated signs and symptoms are present (n=372) 
cy start of dialysis (63%) 
 (31%) 
val (14%) 
R>10.5 ml/min/1.73m2 is never beneficial (n=13) 
e as compared to early start of dialysis (2%) 
ival as compared to early start of RRT (1%) 
were asked “In general, do you think an early start of dialysis (i.e.
erular filtration rate; RRT, renal replacement therapy.entio
t a GF
ergen
 of life
t survi
f also 
ergen
 of life
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nt survlines,11 states that GFR should be estimated using
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iEither always or in the presence of associated symptoms.
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Survey on When to Start Renal Replacement Therapyonly a technique validated in patients with advanced
kidney failure. Although these guidelines mention
calculating the mean of urea and creatinine clearance
as the preferred method, only 15% of our respondents
applied this method. Almost half the nephrologists
reported using eGFR equations alone to guide the start
of dialysis therapy. According to current opinions, this
is problematic because the plasma creatinine concen-
tration used in these equations is determined not only
by GFR, but also by tubular secretion and creatinine
generation rate. Because the latter depends on nutri-
tional status and muscle mass, equations taking solely
demographic variables into account cannot fully pre-
dict the creatinine generation rate.12,13 A recently
updated position statement argues that eGFR equa-
tions are not appropriate to determine the need for
starting RRT because they are not validated in lower
ranges of GFR (30 mL/min/1.73 m2), in other
words, just before initiating dialysis therapy.14-16 Pos-
sibly, nephrologists do not use the recommended
method because in their decision making, they con-
sider the exact level of excretory kidney function less
important than symptoms and social conditions and
therefore may attribute less importance to knowing its
exact value.
Most respondents (86%) believed that only in the
presence of signs and symptoms is starting at GFR
10.5 mL/min/1.73 m2 beneficial. Results of a survey
held in 2000 showed that only 38% of respondents
indicated that signs and symptoms were important
reasons for starting RRT.7 Our survey now adds that
in uncomplicated patients, level of excretory kidney
function is considered the most important factor in the
decision to start RRT by only half of nephrologists, a
percentage decreasing further for patients with unfa-
vorable clinical (24%) or social conditions (32%),
suggesting that the importance of signs and symptoms
has gained importance in comparison to level of
excretory kidney function.
The target eGFR at which nephrologists aimed to
start treatment in uncomplicated patients was 10.0
mL/min/1.73 m2, which is slightly higher than eGFRs
reported by studies using data from patient records, in
which values ranged from 7.5-8.8 mL/min/1.73
m2.4,17-19 Consistent with our finding that only 7%
indicated that the planned start was never delayed, a
possible explanation for these differences may be that
the actual start usually is later than the planned start.
Respondents indicated that the presence of chronic
clinical conditions often resulted in an earlier start of
RRT, in other words, as soon as a permanent access is
available. Results from Lassalle et al19 also showed
higher percentages of older patients and diabetes and
cardiovascular diseases in patients starting at eGFRTable 3. Nephrologist and Facility Characteristics and Their
Associations With Target Level of eGFR at Start of Dialysis in
an Uncomplicated Patient
Determinants
Median eGFR
(95% CI)
Adjusted Median
eGFR (95% CI)
Nephrologist characteristics
Incidence level of country of
residenceb
Lowa 9.1 9.1
Higha 10.3 (9.8-10.9) 10.4 (9.9-10.9)
Sexc
Female 10.2 10.2
Male 9.3 (8.8-9.8) 9.4 (8.9-10.0)
Aged
44 y 10.0 9.9
45 y 9.3 (8.9-9.8) 9.4 (9.0-9.9)
Facility characteristicse
Public vs private
Public center 9.5 9.6
Private center 10.0 (9.4-10.7) 9.8 (9.1-10.6)
Setting
Nonacademic 9.5 9.5
Academic 9.8 (9.3-10.3) 9.7 (9.2-10.2)
Profit status
Nonprofit center 9.4 9.5
For-profit center 10.3 (9.7-11.0) 10.1 (9.5-10.7)
Excretory kidney function most
important factor in
decision to start RRT?f,g
In uncomplicated patients
No 9.3 9.4
Yes 9.9 (9.4-10.4) 9.7 (9.2-10.2)
In patients with unfavorable
social conditions
No 9.5 9.5
Yes 10.0 (9.4-10.6) 9.9 (9.4-10.5)
In patients with unfavorable
clinical conditions
No 9.5 9.5
Yes 9.8 (9.3-10.4) 9.8 (9.3-10.3)
Beneficial to start RRT at GFR
10.5?f,h
No 7.6 8.2
Yesi 9.7 (8.3-11.3) 9.7 (8.3-11.2)
Note: Based on linear regression analyses. eGFRs given in
mL/min/1.73 m2.
Abbreviations: CI, confidence interval; eGFR, estimated glo-
merular filtration rate; RRT, renal replacement therapy.
aLow-incidence countries are Finland, Italy, Romania, Spain,
the Netherlands, and United Kingdom. High-incidence countries
are Belgium, Croatia, Germany, Greece, and FYR of Macedonia.
bAdjusted for sex and age.
cAdjusted for age and country.
dAdjusted for sex and country.
eAdjusted for sex, age, and country.
fAdjusted for sex, age, country, and for-profit center.
gRespondents were asked: “Do you consider the level of
excretory renal function as most important factor in the decision
to start RRT?”
hRespondents were asked: “Do you consider a start of RRT
10.5 mL/min/1.73 m2 as beneficial?”10 mL/min/1.73 m2. Similar results were found by
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start earlier in the elderly and patients with diabetes,
although the difference was only 0.6 mL/min/1.73 m2.
The higher eGFRs in the elderly and patients with
chronic clinical conditions may be the result of malnu-
Table 4. Factors Affecting Timing of Dialysis Initiation in Patie
Chronic clinical conditions
Diabetes mellitus
Age75 y
Chronic heart disease
Cirrhosis or chronic liver disease
Vascular dementia
Other low mental functional statusa
Other clinical conditions
Symptoms of uremia
Fluid overload refractory to diuretic therapy
Progressive deterioration in nutritional status
Life-threatening hyperkalaemia refractory to medical therapy
Pericarditis attributed to uremia
Predictive progressive decrease in GFR within the next mo
Social/logistical conditions
Patient’s preference to start RRT
Wishes of the family to start RRT
Nonadherence to prescribed diet and/or medication
Note: Respondents were asked: “Consider a patient with a lev
postpone dialysis: How would the following conditions affect yo
(percentage).
Abbreviation: GFR, glomerular filtration rate; RRT, renal replac
aFor example, Down syndrome.
Table 5. Factors Affecting Timing of Dialysis Initiation in
Patients for Whom the Nephrologist Generally Would
Start Dialysis
Start of or
Preparation
for Dialysis
Postpone
Dialysis
Patient’s preference to postpone RRT 128 (31) 291 (69)
Wishes of the family to postpone RRT 243 (64) 138 (36)
Long distance to dialysis facility 293 (84) 57 (16)
(Relative) lack of capacity in dialysis
facility
225 (72) 86 (28)
Vascular dementia 130 (34) 255 (66)
Other low mental functional statusa 269 (68) 127 (32)
Nonadherence to prescribed diet
and/or medication
336 (83) 71 (17)
Note: Respondents were asked: “Consider an uncomplicated
patient with the level of residual renal function on which you
would usually decide to start dialysis: How would the following
conditions affect your decision on when to start dialysis?” Values
are given as number (percentage).
Abbreviation: RRT, renal replacement therapy.
aFor example, Down syndrome.
946trition inducing lower serum creatinine levels and
thus higher eGFRs.15 In line with the guidelines, acute
clinical factors such as uremic symptoms and progres-
sive deterioration in nutritional status often resulted in
an immediate start, just like patient’s preference and
availability of a matching pre-emptive transplant from
a living donor, the latter being shown previously by
van Stralen et al21 in pediatric patients.
The start of dialysis therapy often was postponed
by patient’s preference and the presence of vascular
dementia. However, 31% of nephrologists indicated
they start dialysis therapy, or at least start preparations
for dialysis therapy, despite patient preference to
postpone dialysis. Vascular dementia may worsen if
the patient is treated with dialysis, which may explain
why the majority postpone the start of dialysis
therapy.22-24 However, respondents stressed that the
severity rather than the presence of vascular dementia
has a role in their decision making.
We found several differences in opinion when exam-
ining results by nephrologists’ and facilities’ charac-
teristics, for example, regarding the target eGFR in
Table 3, although the clinical relevance may be ques-
tioned considering the low accuracy of eGFR in
patients with ESRD. Respondents from high-inci-
dence countries more often believed that starting at
r Whom the Nephrologist Generally Would Postpone Dialysis
mmediate Start of
Dialysis (With
an Acute Access)
Start of Dialysis
When Permanent
Access Is Ready
Not Start Dialysis
(yet), Even if
Access Is Available
39 (9) 214 (51) 168 (40)
16 (4) 151 (36) 255 (60)
75 (18) 197 (47) 150 (36)
50 (12) 158 (37) 214 (51)
10 (2) 108 (25) 312 (73)
13 (3) 210 (49) 205 (48)
372 (86) 59 (14) 2 (1)
420 (97) 12 (3) 1 (1)
228 (53) 204 (47) —
431 (100) 2 (1) —
425 (98) 6 (1) 1 (1)
45 (11) 329 (77) 53 (12)
24 (6) 305 (70) 104 (24)
12 (3) 233 (54) 185 (43)
32 (8) 252 (59) 142 (33)
residual renal function on which you would usually decide to still
cision on when to start dialysis?” Values are given as number
t therapy.nts fo
I
el of
ur de
emenGFR 10.5 mL/min/1.73 m2 is beneficial, although
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Survey on When to Start Renal Replacement Therapyeven in high-incidence countries, this share was only
18%. Respondents from low-incidence countries seem
less inclined to start RRT sooner in patients with older
age and chronic conditions (such as vascular dementia
or chronic heart disease). They also more often would
postpone treatment because of a relative lack of dialy-
sis capacity and reported a waiting list for long-term
dialysis treatment. Because old age and chronic heart
disease are common, these observed differences may
be relevant for explaining the variation in take-on
rates. Nephrologists in high-incidence countries were
more eager to start RRT at higher GFRs and more
inclined to start in less healthy patients; the opinions
thus are reflected in actual practice. Nephrologists
from private and for-profit centers less often had a
waiting list for long-term dialysis treatment than those
from public and not-for-profit centers. We speculate
that in some cases, these differences by organizational
status may reflect a supply-led demand rather than the
best patient interest. If a private or for-profit center
has the capacity, they may start RRT earlier compared
with public or not-for-profit centers. However, in
these public centers, dialysis sometimes cannot be
started because of a lack of capacity.25 Previous
studies showed a positive association between RRT
incidence and the share of private for-profit HD facili-
ties.26,27 Our results are in line with them and add that
the higher incidence may be caused in part by apply-
ing higher target eGFRs at RRT initiation.
With this international survey including 11 Euro-
pean countries, we examined a wide range of current
opinions of nephrologists’ on their decision for when
to start RRT. Since the previous survey on this matter
in 2000, several debates and cohort studies were
published suggesting that starting RRT at higher
eGFRs may be harmful.2-6,8,12,14,18,19,28 Therefore,
we needed an update regarding current opinions on
this topic.
Limitations of this study are that we were unable to
calculate the exact response rate, and with our sample
size, the generalizability of our results could be ques-
tioned. We did not know how many of those receiving
the survey were nephrologists and were involved in
decision making for when to start RRT. Nevertheless,
based on a worst case scenario, assuming that all
nephrologists received the survey and were eligible
for participation, we estimated a low response rate.
However, surveys with a low response rate do not by
definition have nonresponse bias.29,30 A sensitivity
analysis using only countries with a response 10%
provided similar results. Because we lacked informa-
tion for nonresponders, we do not know whether and
to what extent nonresponse bias affected our results.
Another potential limitation is that respondents gave
socially desirable answers because the subject ad-
Am J Kidney Dis. 2012;60(6):940-948dressed an extensively debated topic. We tried to
minimize this by emphasizing the anonymous data
collection. Additionally, nephrologists with a special
interest and strong opinions may have been more
eager to respond (volunteer bias). Finally, we con-
ducted this survey several months after publication of
the IDEAL trial, but respondents were asked to report
their opinions prior to this publication; therefore,
recall bias may have had a role.
In conclusion, our results provided insight into
what is considered current best practice from nephrolo-
gists’ point of view and we showed that signs and
symptoms are important in decision making for when
to start RRT. In the absence of those symptoms, level
of excretory kidney function is considered the most
important factor by only half the nephrologists. Re-
spondents reported that they would start RRT sooner
on account of chronic conditions and patient prefer-
ence, but significant acceleration in RRT initiation
was reported to be triggered by acute clinical fac-
tors such as hyperkalemia, uremic symptoms, and
fluid overload. Whereas our survey focused on
nephrologists’ opinions, future research should in-
clude an additional focus on patients’ perspectives.
Before being able to optimize medical practice in
relation to starting RRT, we first need to assess the
importance of medical and shared decision making
for patient prognosis.
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